Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
obesity
combination-therapy
glp-1-agonist
gip-agonist
glucagon-agonist
amylin-agonist
